Upstream Bio, Inc. (UPB)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$6.01-1.15%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · UPB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | 3.2 | 2.9 | 2.4 | 2.4 | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 145.8 | 136.8 | 63.0 | 31.8 | — |
| Operating Income | (170.0) | (160.4) | (77.8) | (40.1) | — |
| Earnings from Continuing Operations | |||||
| Interest & Investment Income | 13.5 | 16.9 | 12.1 | 4.2 | — |
| Other Non-Operating Income / Expenses | 13.5 | 16.9 | 15.0 | 19.6 | — |
| Income Tax Expense | — | — | — | 0.0 | — |
| Net Income | |||||
| Net Income | (156.5) | (143.4) | (62.8) | (20.5) | — |
| Per Share | |||||
| Basic EPS | (2.87) | (2.66) | (5.58) | (12.95) | — |
| Diluted EPS | (2.87) | (2.66) | (5.58) | (12.95) | — |
| Revenue per Share | 0.06 | — | — | — | — |
| Basic Weighted Avg Shares | 54.6 | 53.9 | 13.7 | 3.0 | — |
| Diluted Weighted Avg Shares | 54.6 | 53.9 | 13.7 | 3.0 | — |
| Supplemental | |||||
| EBITDA | — | (160.2) | (77.7) | (40.1) | — |
| EBIT | (170.0) | (160.4) | (77.8) | (40.1) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.